Today, numerous carbon fiber (CF) reinforced plastic (CFRP) components are in continuous usage under harsh environmental conditions. New components often replace damaged structural parts in safety-critical applications. In addition to this, there is also no effective repair method to initially restore the mechanics of these structures using dry fiber material. The high costs of CFRP components are not in proportion to their lifetime. The research project IGF-19946 BR "CFRP-Repair" addresses this specific challenge. By using an oxide semiconductor that is activated by ultraviolet (UV) irradiation, the thermoset matrix can be depolymerized and thus locally removed from the damaged CFRP component. Afterward, the harmed fibers can be physically removed from the laminate in this certain area. A load-adjusted tailored fiber reinforcement patch is subsequently applied and consolidated by local thermoset re-infiltrating. Using this procedure, the structure can be locally repaired with new CF. As a result, repaired CFRP structures can be obtained with reduced mechanics and an approximately original surface. This article gives an insight into the developed repair procedure of CFRP components in an innovative and more efficient way than the state-of-the-art.Exercise self-efficacy, the confidence a person has in their ability to develop and meet exercise goals, is key to exercise motivation. The primary objective of this pilot study was to explore associations among cognitive exercise self-efficacy, cognitive exercise frequency, challenge, and enjoyment in older adults. A prospective, cross-sectional, observational study design was used with 133 community-dwelling individuals aged 55 years and older. Respondents completed a cognitive exercise self-efficacy scale and responded to cognitive exercise queries. Individuals who engaged in cognitive exercise demonstrated greater cognitive exercise self-efficacy. Cognitive exercise self-efficacy ratings were significantly different across challenge and enjoyment conditions (Pearson's χ2 test, df = 9, N = 133, χ2 = 123.49, p less then 0.01), such that the greater the perception of each, the greater the cognitive exercise self-efficacy (p less then 0.01). The comparative impact of perceived enjoyment on cognitive exercise self-efficacy was greater than the impact of perceived challenge. Study findings support positive associations among cognitive exercise self-efficacy, cognitive exercise frequency, challenge, and enjoyment. Consideration of these findings may inform design and sustained implementation of motivating cognitive exercise programs to maximize health and quality of life outcomes of healthy and neurologic older adult populations.The present study addresses the incorporation of fine particles into liquids via the creation of a large-scale swirling vortex on the liquid free surface using a rotary impeller positioned along the axis of a cylindrical vessel. Four types of particles are used in the experiments to investigate the incorporation efficiency of the particles into a water bath under different impeller rotation speeds. Additionally, the vortex characteristics are investigated numerically. The results reveal that two factors, namely the particle wettability and turbulent oscillations at the bottom part of vortex surface, play dominant roles in determining the particle incorporation behavior. Hydrophobic particles are incapable of being incorporated into the water bath under any of the conditions examined in the present study. Partly wettable particles are entrained into the water bath, with the efficiency increasing with the impeller rotation speed and particle size. This is because an increase in the impeller rotation speed causes vortex deformation, whereby its bottom part approaches the impeller blades where the turbulent surface oscillations reach maximum amplitudes. Another possible mechanism of particle incorporation is the effect of capillary increases of liquid into the spaces between particles, which accumulate on the bottom surface of the vortex.The lack of an efficient approach in managing pharmaceutical prices in the procurement system led to a substantial burden on government budgets. In Thailand, although the reference price policy was implemented to contain the drug expenditure, there have been some challenges with the price dispersion of medicines and pricing information transparency. This phenomenon calls for the development of a potential algorithm to estimate appropriate prices for medical products. To serve this purpose, in this paper, we first developed the model by the sequential minimal optimization (SMO) algorithm for predicting the range of the prices for each medicine, using the Waikato environment for knowledge analysis software, and applying feature selection techniques also to examine improving predictive accuracy. We used the dataset comprised of 2424 records listed on the procurement system in Thailand from January to March 2019 in the application and used a 10-fold cross-validation test to validate the model. The results demonstrated that the model derived by the SMO algorithm with the gain ratio selection method provided good performance at an accuracy of approximately 92.62%, with high sensitivity and precision. Additionally, we found that the model can distinguish the differences in the prices of medicines in the pharmaceutical market by using eight major features-the segmented buyers, the generic product groups, trade product names, procurement methods, dosage forms, pack sizes, manufacturers, and total purchase budgets-that provided the highest predictive accuracy. Our findings are useful to health policymakers who could employ our proposed model in monitoring the situation of medicine prices and providing feedback directly to suggest the best possible price for hospital purchasing managers based on the feature inputs in their procurement system.COVID-19 is a respiratory disease caused by newly discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease at first was identified in the city of Wuhan, China in December 2019. Being a human infectious disease, it causes high fever, cough, breathing problems. In some cases it can be fatal, especially in people with comorbidities like heart or kidney problems and diabetes. https://www.selleckchem.com/products/BMS-790052.html The current COVID-19 treatment is based on symptomatic therapy, so finding an appropriate drug against COVID-19 remains an immediate and crucial target for the global scientific community. Two main processes are thought to be responsible for the COVID-19 pathogenesis. In the early stages of infection, disease is determined mainly by virus replication. In the later stages of infection, by an excessive immune/inflammatory response, leading to tissue damage. Therefore, the main treatment options are antiviral and immunomodulatory/anti-inflammatory agents. Many clinical trials have been conducted concerning the use of various drugs in COVID-19 therapy, and many are still ongoing.